Anxiety Symptoms in Relation to Use of Hemp-derived, Full Spectrum Cannabidiol (CBD)

Clinical trial NCT05023759 · COMPLETED

Trial details

NCT number: NCT05023759
Sponsor: Formula30A LLC
Status: COMPLETED
Study type: OBSERVATIONAL

Generalized Anxiety Disorder

Start date: 2020-06-01
Primary completion: 2020-10-31
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.